Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) is a common cause of
chronic liver disease globally, with prevalence rapidly increasing in parallel with rising rates …

Sarcopenia and metabolic dysfunction associated steatotic liver disease (MASLD) are
closely intertwined. Sarcopenia, traditionally a disease of the older adult and chronic …

Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a liver disorder
characterized by steatosis with underlying metabolic risk factors. The prevalence of MASLD …

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects more than 30% of
the world's adult population. While it is associated with obesity and metabolic syndrome …

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …

Abstract Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD) is a disease
spectrum encompassing liver injury with progressive severity, tightly connected to the …

The prevalence of metabolic-associated fatty liver disease (MAFLD) has increased
substantially in recent years because of the global obesity pandemic. MAFLD, now …

Muscle‐wasting and disease‐related malnutrition are highly prevalent in patients with
chronic liver diseases (CLD) as well as in liver transplant (LT) candidates. Alterations of …

Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as the most
common chronic liver disease globally, affecting more than a third of the world's adult …

Sarcopenia, defined as the loss of muscle strength, mass, and functionality, confers a poor
prognosis in the setting of cirrhosis. Given its clinical significance, a better understanding of …